Determination of hepatitis C virus genotypes among hepatitis C patients in eastern black sea region, Turkey;Doǧu Karadeniz bölgesi hepatit C hastalarinda hepatit C virusu genotiplerinin belirlenmesi

Mikrobiyoloji Bulteni

Volumn 47, Issue 4, 2013, Pages 650-657

  Buruk, Celai Kurtuluş ^a   Bayramoǧlu, Gülçin ^a   Reis, Ahu ^a   Kaklikkaya, Neşe ^a   Tosun, Ilknur ^a   Aydin, Faruk ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Eastern Black Sea Region; Genotyping; Hepatitis C virus; Turkey

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; TURKEY (REPUBLIC); VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; TURKEY; YOUNG ADULT;

EID: 84890391924     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: 10.5578/mb.5796     Document Type: Article

References (30)

1. Kuo G, Choo QL, Alter H.J., et al An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science Apr 1989; 244(4902): 362-4.
2. Simmonds P, Bukh J, Combet C., et al Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42(4): 962-73.
3. Sünbül M. HCV enfeksiyonunun epidemiyolojisi ve korunma, s: 208-19. Tabak F, Tekeli E, Balik I (ed), Viral Hepatit 2007. 2007, 1. baski. Deniz Ofset, Istanbul.
4. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005; 10(1): 1-11.
5. Abacioglu YH, Davidson F, Tuncer S., et al The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 1995; 2(6): 297-301.
6. Özaçar T, Altuglu I, Zeytinoglu A ve ark. Kronik C hepatitinde HCV genotiplerinin daǧilimi. Mikrobiyol Bul 2001; 35 (3): 451-8.
7. Kalayci R, Altindis, M, Gülamber G, Demirtürk N, Akcan X Demirdal T. Kronik hepatit B ve hepatit C'li has-talarda genotip daǧilimi ve hepatit B olgularinda direnç paterninin araştirilmasi. Mikrobiyol Bul 2010; 44(2): 237-43.
8. Şanlidaǧ T, Akçali S, Özbakkaloǧlu B, Ertekin D, Akduman E. Manisa bölgesinde hepatit C virus genotiplerinin daǧilimi. Mikrobiyol Bul 2009; 43(4): 613-8.
9. Küçüköztaş MF, Özgünes. N, Yazici S. Kronik hepatit C'li hastalarda hepatit C virusu (HCV) genotipleri ile alanin aminotransferaz ve HCV-RNA düzeyleri arasmdaki ilişkinin araştirilmasi. Mikrobiyol Bul 2010; 44(1): 111-5.
10. Aktaş E, Ogedey ED, Külah C, Beǧendik Cömert F. Zonguldak bölgesinde hepatit C virusu genotipleri. Mikrobiyol Bul 2010; 44(4): 647-50.
11. Bozdayi G, Verdi H, Rota S ve ark. Hemodiyaliz hastalannda hepatit C virus enfeksiyon varliǧinin araştirilmasi ve HCV genotip daǧliminin belirlenmesi. Mikrobiyol Bul 2002; 36 (3): 291-304.
12. Ural O, Arslan U, Findik D. Konya bölgesinde hepatit C virusu genotip daǧilimi. Infeksiyon Dergisi 2007; 21(4): 175-81.
13. Çelik C, Bakici M.Z., Kaygusuz R., Ertiirk R. Sivas yöresindeki HCV genotip daǧilimlarinin araştirilmasi. Viral Hepatit Derg 2010; 16(3): 106-10.
14. Gökahmetoǧlu S, Atalay MA, Kilinç A. Hepatit C virus genotiplerinin pirosekanslama yöntemi ile belirlenmesi. Erciyes Tip Derg 2011; 33(2): 99-102.
15. Yarkin F, Hafta A. Kronik hepatit C enfeksiyonu olan hastalarda hepatit C virus (HCV) genotiplerinin daǧilimi. Viral Hepatit Derg 2000; 6(3): 164-8.
16. Çil T, Özekinci T, Cöral V, Altintaş, A. Güneydo4gKu Anadolu Bölgesi'nde hepatit C virüsü genotipleri. Turkiye Klinikleri J Med Sci 2007; 27(4): 496-500.
17. Kayman T, Karakiikçü Ç, Karaman A, Gözütok F. Kayseri bölgesinde hepatit C virüs enfeksiyonunun genotip daǧilimi. Türk Mikrobiyol Cem Derg 2012; 42(1): 21-6.
18. Tezcan S, Ulger M, Asian G ve ark. Mersin ilinde hepatit C virusu genotip daǧiliminm belirlenmesi. Mikrobiyol Bul 2013; 47(2):332-8.
19. EASL International Consensus Conference on Hepatitis C. Paris, 26-28 February 1999, Consensus Statement. European Association for the Study of the Liver. J Hepatol 1999; 30(5): 956-61.
20. Mangia A, Ricci GL, Persico M, et al A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-na-ve patients with chronic hepatitis C. J Viral Hepat 2005; 12(3): 292-9.
21. Kim SR, El-Shamy A, Imoto S., et al Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load. J Gastroenterol 2012; 47(10): 1143-51.
22. Foster GR, Hézode C, Bronowicki J.P., et al Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections. Gastroenterology 2011; 141(3): 881-9.
23. Cantaloube JF, Gallian P, Attoui H., Biagini P, De Micco P, de Lamballerie X. Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France. J Clin Microbiol 2005; 43(8): 3624-9.
24. Weck K. Molecular methods of hepatitis C genotyping. Expert Rev Mol Diagn 2005; 5(4): 507-20.
25. Ghany MG, Strader DB, Thomas D.L., Seeff LB Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49(4): 1335-74.
26. Ohno O, Mizokami M, Wu R.R., et al New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35(1): 201-7.
27. Furione M, Simoncini L, Gatti M., et al HCV genotyping by three methods: analysis of discordant results based on sequencing. J Clin Virol 1999; 13(3): 121-30.
28. Ciotti M, Marcuccilli F, Guenci T., et al A multicenter evaluation of the Abbott RealTime HCV Genotype II assay. J Virol Methods 2010; 167(2): 205-7.
29. Schutzbank TE, Sefers SE, Kahmann N, Li H., Tang YW Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping. J Clin Microbiol 2006; 44(10): 3797-8.
30. Nolte FS, Green AM, Fiebelkorn K.R., et al Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region. J Clin Microbiol 2003; 41(4): 1558-64.